Standout Papers
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (2018)
- The 2019 WHO classification of tumours of the digestive system (2019)
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2018)
- The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival (2012)
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines (2021)
Immediate Impact
12 by Nobel laureates 25 from Science/Nature 103 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
Works of Peter Schirmacher being referenced
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma
2021
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Schirmacher | 11352 | 10719 | 7438 | 10370 | 673 | 35.7k | |
| Andrew X. Zhu | 12437 | 7426 | 6482 | 16657 | 415 | 33.7k | |
| Jia Fan | 11941 | 16481 | 12431 | 8447 | 805 | 38.0k | |
| Richard S. Finn | 15770 | 8749 | 8000 | 15213 | 364 | 36.6k | |
| Irene Oi‐Lin Ng | 10970 | 17913 | 11109 | 18202 | 620 | 46.6k | |
| Lewis R. Roberts | 6113 | 9202 | 6406 | 12828 | 417 | 28.4k | |
| Jessica Zucman‐Rossi | 7056 | 13603 | 7640 | 8712 | 317 | 30.8k | |
| Yoshihiko Maehara | 13290 | 11091 | 5533 | 8559 | 1.7k | 42.1k | |
| Ann‐Lii Cheng | 10169 | 7775 | 4431 | 9776 | 784 | 27.4k | |
| Vincenzo Mazzaferro | 7444 | 6276 | 5910 | 24135 | 357 | 36.6k | |
| Bruno Sangro | 7306 | 4072 | 3400 | 15541 | 410 | 24.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...